After competitor Novo Nordisk's diet pills were approved by the US Food and Drug Administration, Eli Lilly's stock price fell 1.2% in pre-market trading.

Zhitongcaijing · 2d ago
After competitor Novo Nordisk's diet pills were approved by the US Food and Drug Administration, Eli Lilly's stock price fell 1.2% in pre-market trading.